Concepedia

Sarah J. Welsh

SJ

Statistics

Publications

40

Citations

5.6K

H-Index

32

Active since

2001

Affiliations

Cambridge University Hospitals NHS Foundation Trust(Current)

University of Cambridge

Wellcome Sanger Institute

The University of Texas MD Anderson Cancer Center

Addenbrooke's Hospital

Sarah J. Welsh is an author at Cambridge University Hospitals NHS Foundation Trust specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2001–2023

40

Publications

40

Regulation of an <i>ATG7</i> - <i>beclin 1</i> Program of Autophagic Cell Death by Caspase-8

Li Yu, Ajjai Alva, Helen C. Su et al. · Science · 2004 · 1.2K citations

, , +16

Autophagic programmed cell death by selective catalase degradation

Li Yu, Fengyi Wan, Sudeshna Dutta et al. · Proceedings of the National Academy of Sciences · 2006 · 661 citations · Full text

, , +15

The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.

Sarah J. Welsh, William Bellamy, Margaret M. Briehl et al. · PubMed · 2002 · 349 citations

, , +17

Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1α

Mei Yee Koh, Taly R. Spivak-Kroizman, Sara Venturini et al. · Molecular Cancer Therapeutics · 2008 · 305 citations · Full text

, , +13

Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha.

Sarah J. Welsh, Ryan Williams, Lynn Kirkpatrick et al. · PubMed · 2004 · 281 citations

, , +17

1–5 of 40